Back to search

Spain· ES:42610

MAXITROL 3.500 UI/ML + 6.000 UI/ML + 1 MG/ML COLIRIO EN SUSPENSIÓN

A medicinal product containing dexametasona + neomicina + polimixina b, registered in Spain by Novartis Farmaceutica S.A..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedMAXITROL 3.500 UI/ML + 6.000 UI/ML + …ATC—REGISTER NO.ES:42610PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
dexametasona + neomicina + polimixina B
Manufacturer
Novartis Farmaceutica S.A.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dexametasona + neomicina + polimixina b in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexametasona + neomicina + polimixina b products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a1e825d0-8bce-47ee-9ba5-56a57b6c0c5f
GET /v1/drugs/a1e825d0-8bce-47ee-9ba5-56a57b6c0c5f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":-110595600000}",
  "nregistro": "42610",
  "substance": "dexametasona + neomicina + polimixina B"
}

See everything about dexametasona + neomicina + polimixina b.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.